COLCHICINE | N210942 | SCILEX PHARMACEUTICALS INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
| D. Del. | 2023-11-06 | Terminated 2024-05-03 | — | |
| D. Del. | 2020-07-01 | Terminated 2022-03-25 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Mutual Pharmaceutical Company, Inc. (Sidley Austin LLP) - Citizen Petition FDA-2012-P-1018 · 3 docket documents Mutual Pharmaceutical Company, Inc. filed this citizen petition under Section 505 of the Federal Food, Drug, and Cosmetic Act and associated regulations requesting that the FDA refrain from approving any Abbreviated New Drug Application for a generic colchicine product referencing its brand-name dru | 505(q) | 2012-10-04 | Denied | — |
Citizen Petition from Par Pharmaceutical FDA-2012-P-0632 · 5 docket documents Par Pharmaceutical submitted this citizen petition under Section 505(j)(2)(C) of the Federal Food, Drug, and Cosmetic Act requesting that the Commissioner determine that Colchicine Tablets in strengths of 0.3 mg, 1.2 mg, and 1.8 mg are suitable for submission as an ANDA, with Colcrys Tablets 0.6 mg | Other | 2012-06-15 | Partially Denied | Par Pharmaceutical |
Source: Regulations.gov. FDA citizen petitions matched by application number.